novo nordisk pfizer - Search News

Pfizer, Novo Nordisk and Metsera

Pfizer Sues Seeking to Block Novo Nordisk’s Effort to Undo Weight-Loss Drug Deal

Drugmaker Pfizer on Friday sued obesity-drug developer Metsera and Novo Nordisk, seeking to block Metsera from terminating its multibillion-dollar merger deal with Pfizer after Novo Nordisk made an unsolicited takeover bid.

Axios on MSN · 2h

Pfizer files lawsuit to block Novo Nordisk's bid for Metsera

· 2h

Pfizer Files Lawsuit Against Metsera and its Directors and Novo Nordisk for Breach of Merger Agreement

· 1d

Novo Nordisk launches bidding war with Pfizer for US obesity biotech Metsera

Denmark's Novo Nordisk launched a rival bid for U.S. obesity biotech firm Metsera on Thursday, hijacking an offer from Pfizer as the drugmakers jostled for advantage in the highly lucrative weight-los...

· 1d

Novo tops Pfizer with $6.5B bid for Metsera

· 1h

Pfizer sues to stop rival bid for drugmaker Metsera by Denmark's Novo Nordisk

· 1d

Novo Nordisk changes tack with bold raid on Pfizer obesity deal

"We asked them to become more aggressive and ambitious," said Mikael Bak, head of the Danish Shareholders' Association which has around 17,000 members, most of them investors in Novo.

· 1d

Pfizer Fires Back as Novo Nordisk Hijacks Its $8.5 Billion Metsera Deal

· 1d

Novo Nordisk starts bidding war with Pfizer over US biotech Metsera

Devdiscourse

Pfizer Battles Legal Storm Over Metsera Merger: A High-Stakes Court Drama

Pfizer has filed a lawsuit against Metsera and Novo Nordisk, claiming Metsera violated its merger agreement by entertaining Novo's superior bid offer. Pfizer seeks a court order to prevent Metsera from terminating their agreement,